4.5 Review

The role of microvesicles containing microRNAs in vascular endothelial dysfunction

Journal

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 23, Issue 12, Pages 7933-7945

Publisher

WILEY
DOI: 10.1111/jcmm.14716

Keywords

atherosclerosis; endothelial dysfunction; inflammation; microRNA; microvesicle

Funding

  1. Natural Science Foundation of Tianjin City [14JCYBJC27800]
  2. National Natural Science Foundation of China [14JCYBJC27800]
  3. Tianjin Natural Science Foundation
  4. Major Special Project for the Prevention and Control of Chronic Diseases in Tianjin [17ZXMFSY00080]

Ask authors/readers for more resources

Many studies have shown that endothelial dysfunction is associated with a variety of cardiovascular diseases. The endothelium is one of the primary targets of circulating microvesicles. Besides, microRNAs emerge as important regulators of endothelial cell function. As a delivery system of microRNAs, microvesicles play an active and important role in regulating vascular endothelial function. In recent years, some studies have shown that microvesicles containing microRNAs regulate the pathophysiological changes in vascular endothelium, such as cell apoptosis, proliferation, migration and inflammation. These studies have provided some clues for the possible roles of microvesicles and microRNAs in vascular endothelial dysfunction-associated diseases, and opened the door towards discovering potential novel therapeutic targets. In this review, we provide an overview of the main characteristics of microvesicles and microRNAs, summarizing their potential role and mechanism in endothelial dysfunction, and discussing the clinical application and existing problems of microvesicles for better translational applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available